SCHEMBL15031323

SCHEMBL15031323

COC(=O)C[C@](O)(CCCC(C)C)C(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA12 O43570 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15031322 0.91 L3MBTL1 (0.41) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL22433237 0.85 MEN1 (0.36) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL12745456 0.85 RECQL (0.36) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL12746062 0.81 MEN1 (0.34) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL12826647 0.81 TSHR (0.34) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL28029276 0.79 MEN1 (0.39) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL15806369 0.77 MEN1 (0.41) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL16254847 0.77 L3MBTL1 (0.41) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL10029375 0.77 MEN1 (0.41) RECQLMEN1KMT2AHPGDHSD17B10
SCHEMBL12745455 0.76 L3MBTL1 (0.40) RECQLMEN1KMT2AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006231-B2 Cephalotaxus esters, methods of synthesis, and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-04-14 US disclosed
US-20140171416-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2014-06-19 US disclosed
US-8466142-B2 Cephalotaxus esters, methods of synthesis, and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2013-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171416-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF COASY, CXCR4, CETP RECQL 1717/4885MEN1 165/4885KMT2A 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.